Compare ASX & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASX | BDX |
|---|---|---|
| Founded | 1984 | 1897 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.7B | 51.5B |
| IPO Year | 2000 | 1995 |
| Metric | ASX | BDX |
|---|---|---|
| Price | $26.85 | $155.73 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $186.92 |
| AVG Volume (30 Days) | ★ 5.9M | 2.0M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | 0.98% | ★ 2.70% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.34 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | $18.83 | N/A |
| Revenue Next Year | $15.39 | $2.22 |
| P/E Ratio | ★ $38.05 | $115.95 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $7.86 | $152.79 |
| 52 Week High | $26.55 | $213.08 |
| Indicator | ASX | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 74.51 | 39.01 |
| Support Level | $20.63 | $153.75 |
| Resistance Level | N/A | $160.19 |
| Average True Range (ATR) | 0.70 | 3.02 |
| MACD | 0.54 | 1.05 |
| Stochastic Oscillator | 98.42 | 39.77 |
ASE Technology Holding Co Ltd is a semiconductor assembly and testing firm. The company operates in segments: Packaging, Testing, Electronic Manufacturing Services and others. Of these, Packaging segment contribute the maximum revenue. The packaging segment involves packaging bare semiconductors into completed semiconductors with improved electrical and thermal characteristics. The Testing Segment includes front-end engineering testing, wafer probing, and final testing services. In the EMS segment, the company designs manufactures, and sells electronic components and telecommunication equipment motherboards. The company is based in Taiwan but generates over half its sales from firms in the United States.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.